Novo Nordisk's best-selling weight loss drug now joins Madrigal Pharmaceuticals' Rezdiffra (resmetirom) on the market, which was the first medication to be approved in noncirrhotic MASH in March 2024
Use protein-rich foods and supplements like Unjury to help meet your protein goals
Dose reduction for maintenance Some researchers step down their dose after reaching target weight
However, fainting, though rare, is a potential side effect
Vidal-Casariego 2013 meta-analysis: Four RCTs with 284 type 2 diabetes patients showed 23 g/day L-carnitine for 1252 weeks reduced fasting glucose, total cholesterol, LDL cholesterol, and apolipoproteins B100 and A1 but NOT triglycerides, lipoprotein(a), or HbA1c [3][43]
The concentration of semaglutide varies by brand and formulation